Cannell Capital’s LeMaitre Vascular LMAT Stock Holding History

Cannell Capital’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-413,849	Closed	-$5.04M	–	58
2015 Q3	$5.04M	Sell	413,849 -349,416	-46%	-$4.48M	1.89%	18
2015 Q2	$9.21M	Sell	763,265 -146,274	-16%	-$1.44M	3.01%	11
2015 Q1	$7.62M	Hold	909,539	–	–	2.38%	15
2014 Q4	$6.96M	Hold	909,539	–	–	2.3%	16
2014 Q3	$6.26M	Hold	909,539	–	–	2.35%	18
2014 Q2	$7.52M	Buy	909,539 +100,000	+12%	+$782K	2.61%	13
2014 Q1	$6.51M	Buy	809,539 +108,711	+16%	+$870K	2.32%	15
2013 Q4	$5.61M	Sell	700,828 -7,414	-1%	-$57.3K	2.28%	17
2013 Q3	$4.74M	Buy	708,242 +30,896	+5%	+$209K	2.32%	14
2013 Q2	$4.43M	Buy	+677,346	New	+$4.27M	2.63%	16

Other funds holding LMAT

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Cannell Capital's LMAT Position: Q4 2015 in Review

Cannell Capital sold out of LeMaitre Vascular (LMAT) in Q4 2015, closing a stake of 413,849 shares — an estimated $5.04M sold.

Cannell Capital first reported a position in LMAT in Q2 2013 and held it in 10 quarters. The position peaked at $9.21M in Q2 2015. 92 funds tracked by Wall St. Rank hold LMAT as of Q4 2015.

Cannell Capital reported no remaining LeMaitre Vascular position as of Q4 2015 after selling out during the quarter.
Cannell Capital sold 413,849 LeMaitre Vascular shares in Q4 2015, an estimated $5.04M.
Cannell Capital first reported a position in LeMaitre Vascular in Q2 2013 and held it in 10 quarters.
Cannell Capital's LeMaitre Vascular position peaked at $9.21M in Q2 2015.
92 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2015.

Based on Cannell Capital's 13F filing for Q4 2015, filed 12 Feb 2016.